0.00Open0.07Pre Close0 Volume8 Open Interest129.00Strike Price0.00Turnover85.86%IV13.68%PremiumOct 4, 2024Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.07Extrinsic Value100Contract SizeAmericanOptions Type0.0252Delta0.0078Gamma1622.00Leverage Ratio-0.0637Theta0.0002Rho40.81Eff Leverage0.0052Vega
Merck & Co Stock Discussion
Next Week 120
$Esperion Therapeutics (ESPR.US)$Is going to be one of those stocks people wish they loaded up on. This isn't a Pump article. Read the facts & decide for yourself. People mostly miss out the the explosive growth curve. Esperion...
$Heron Therapeutics (HRTX.US)$ : 🤔
⇨ ZYNRELEF® Vial Access Needle
‣ Postoperative pain
‣ PDUFA: 9/23/24 (sNDA)
$Bristol-Myers Squibb (BMY.US)$ : 🤔
⇨ KarXT (xanomeline-trospium)
‣ Schizophrenia
‣ PDUFA: 9/26/24 (NDA)
$Sanofi (SNY.US)$ $Regeneron Pharmaceuticals (REGN.US)$ : 🤔
⇨ Dupixent
‣ Chronic obstructive pulmonary disease
‣ PDUFA: 9/27/24 (sBLA)
$BeiGene (BGNE.US)$ $Merck & Co (MRK.US)$ & $Bristol-Myers Squibb (BMY.US)$ : 🤔
⇨ Tislelizumab, KEYTRUDA, OPDIVO & YER...
$Esperion Therapeutics (ESPR.US)$Is going to be one of those stocks you wish you had bought. Esperion is HUGELY Undervalued, company sells the ONLY statin alternative drugs with New FDA approved Primary Prevention Labels in 2024. Insurance companies are j...
The current market-cap is below $350 million, with $200 million cash on hand, and $900 million in future milestones, with $140...
No comment yet